Selenium attenuates ROS-mediated apoptotic cell death of injured spinal cord through prevention of mitochondria dysfunction; in vitro and in vivo study

Cellular Physiology and Biochemistry

Volumn 21, Issue 1-3, 2008, Pages 225-238

  Yeo, Jee Eun ^a   Kim, Jeong Hwan ^a   Kang, Soo Kyung ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

Apoptotic Cell Death Function Recovery; Inflammation; Myelination; Neuroprotection; Selenium; Spinal Cord Injury

Indexed keywords

ADENOSINE TRIPHOSPHATE; CASPASE; CYTOCHROME C; HYDROGEN PEROXIDE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; SELENIUM; SODIUM SELENITE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; ASTROCYTOSIS; CELL VIABILITY; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HISTOLOGY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MACROPHAGE; MICROGLIA; MYELINATION; NEURAL STEM CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; STATISTICAL ANALYSIS; WESTERN BLOTTING;

ANIMALIA; RATTUS;

EID: 38349132592     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000113764     Document Type: Article

References (45)

1. David S, Aguayo AJ: Axonal elongation into peripheral nervous system "bride" after central nervous system injury in adult rats. Science 1981;214:931-933.
2. Taoka Y, Okajima K, Uchiba M, Murakami K, Kushimoto S, Johno M, Naruo M, Okabe H, Takatsuki K: Role of neutrophils in spinal cord injury in the rat. Neuroscience 1997;79:1177-1182.
3. Carlson SL, Parrish ME, Springer JE, Doty K, Dossett L: Acute inflammatory response in spinal cord following impact injury. Exp. Neuro. 1998;151:77-88.
4. Richardson SJ: Free radical in the generation of Alzheimer's disease. Ann N Y Acad Sci 1993;67:119-127.
5. Olanow CW: An introduction to the free radical hypothesis in Parkinson's disease. Ann Neurol 1992:S2-9.
6. Olanow CW: A radical hypothesis for neurodegeneration Trends Neurosci 1997;16:439-444.
7. Bellavite P: The superoxide-forming enzymatic system of phagocytes. Free Radical Biol Med 1988;4:225-261.
8. Giulian D, Vaca K, Corpuz M: Brain glia release factors with opposing actions upon neuronal survival. J Neurosci 1993;13:29-37.
9. Halliwell B, Gutteridge JM: Biologically relevant metal ion-dependent hydroxyl radical generation: an update. Fedn Eur Biochem Socs Lett 1992;307:108-112.
10. Richter C, Kass GE: Oxidative stress in mitochondria: its relationship to cellular Ca2+ homeostasis, cell death, proliferation, and differentiation. Chem Biol Interact 1991;77:1-23.
11. Yu BP: Cellular defenses against damage from reactive oxygen species. Physiol Rev 1994;74:139-162.
12. Limke TL, Rao MS: Neural stem cell therapy in the aging brain: pitfalls and possibilities. J Hematother Stem Cell Res 2000;12:615-623.
13. Le Belle JE, Svendsen CN: Stem cells for neurodegenerative disorders: where can we go from here? BioDrugs 2002;16:389-401.
14. Limoli CL, Giedzinski E, Rola R, Otsuka S, Palmer TD, Fike JR: Radiation response of neural precursor cells: linking cellular sensitivity to cell cycle checkpoint, apoptosis and oxidative stress Radiat Res 2004;161:17-27.
15. Liu X, Kim CN, Yang Y, Jemmerson R, Wang X: Induction of apoptosis program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996:86;145-157.
16. Murphy MP, Smith RA: Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 2000;41:235-250.
17. Kluck RM, Bossy-Wetzel E, Green DR, Newmeywer DD: The release of cytochrome c from mitochodria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-1136.
18. Itoh NM, Tsujimoto Y, Nagata S: Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 1993;151:621-627.
19. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 1997;387:773-776.
20. Bruce-Keller AJ, Begley JG, Fu W, Butterfield DA, Bredesen DE, Hutchins JB, Hensley K, Mattson MP: Bcl-2 protects isolated plasma and mitochondrial membranes against lipid peroxidation induced by hydrogen peroxide and amyloid B-peptide. J Neurochem 1998;70:31-39.
21. Desagher S, Martinou JC: Mitochondria as the central control point of apoptosis. Trends Cell Biol 2000;10:369-377.
22. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG: Selenium: biochemical role as a component of glutathione peroxidase. Science 1973;179:588-590.
23. Harman D: Free radicals and age-related disease, in Free Radicals in Aging 1993:pp.205-222.
24. Marcocci L, Floche L, Packer L: Evidence for a functional role of the selenocysteine residue in mammalian thioredoxin reductase. Biofactors 1997;6:351-358.
25. Lee SR, Bar-Noy S, Kwon S, Levine RL, Stadtman TC, Rhee SG: Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. roc Natl Acad Sci USA 2000;97:2521-2526.
26. Imam SZ, Newport GD, Islam F, Slikker W, Jr Ali SF: Selenium, an antioxidant, ptotects against methamphetamine-induced dopaminergic neurotoxicity. Brain Res 1999;818:575-578.
27. Kang SK, So HH, Moon YS, Kim CH: Proteomic analysis of injured spinal cord tissue proteins using 2DE and MALDITOF. Proteomics 2006;6(9):2797-2812.
28. Dexter DT, Carter CJ, Wells FR, Javoy-Agid Y, Lees A, Jenner P, Marsden CD: Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989;52:381-389.
29. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer disease. Proc Nat Acad Sci USA 1991;88:10540-10543.
30. Tan S, Wood M, Maher P: Oxidative stress induces a form of programmed cell death with characteristics of both apoptosis and necrosis in neuronal cells. J Neurochem 1995;71:95-105.
31. Ragusa RJ, Chow CK, Porter JD: Oxidative stress as a potential pathogenic mechanism in an animal model of Duchenne muscular dystrophy. Neuromuscul. Disord 1997;7:379-386.
32. Cornett CR, Markesbery WR, Ehmann WD: Imbalances of the trace elements related to oxidative damage in Alzheimer disease brain. Neurotoxicology 1998;19:339-345.
33. Facchinetti F, Dawson VL, Dawson TM: Free radicals as mediators of neuronal injury. Cell Mol Neurobiol 1998;18:667-682.
34. Sagara Y, Tan S, Maher P, Schubert D: Mechanisms of resistance to oxidative stress in Alzheimer's disease brain. Neurotoxicology 1998;19:339-345.
35. Kim TS, Jeong DW, Yun BY, Kim IY: Dysfunction of rat liver mitochondria by selenite: induction of mitochondrial permeability transition through thioloxidation. Biochem Biophys Res Commun 2002;294:1130-1137.
36. Skaper SD: Poly (ADP-Ribose) polymerase-1 in acute neuronal death and inflammation: a strategy for neuroprotection. Ann NY Acad Sci 2003;993:217-228.
37. Whalen MJ, ClarkRS, Dixon CE, Robichaud P, Marion DW, Vagni V, Graham S, Virag L, Hasko G, Stachlewitz R: Traumatic brain injury in mice deficient in poly-ADP (ribose) polymerase: a preliminary report. Acta Neurochir Suppl 2000;76:61-64.
38. LaPlac MC, Zhang J, Raghupathi R, Li JH, Smith F, Bareyre FM, Snyder SH, Graham DI, McIntosh TK: Pharmacologic inhibition of poly (ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats. J Neurotrauma 2001;18:369-376.
39. Scott GS, Jakeman LB, Stokes BT, Szabo C: Peroxynitrite production and activation of poly (adenosine diphosphate-ribose) synthetase in spinal cord injury. Ann Neurol 1999;45:120-124.
40. Burkle A: Physiology and pathophysiology of poly(ADPribosyl) ation. BioEssays 2001;23:795-806.
41. Blight AR: Cellular morphology of chronic spinal cord injury in the cat: analysis of myelinated axons by line-sampling. Neurosci 1983;10:521-543.
42. Teng YD, Choi H, Onario RC, Zhu S, Desilets FC, Lan S, Woodard EJ, Snyder EY, Eichler ME, Friedlander RM: Minocycline inhibits contusion-triggered mitochondrial cytochrome c release and mitigates functional deficits after spinal cord injury. PNAS 2004;101:3071-3076.
43. Holstege G: Descending motor pathways and the spinal motor system: limbic and non-limbic components. Prog Brain Res 1991;87:307-421.
44. Jones LL, Margolis RU, Tuszynski MH: The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury. Exp Neurol 2003;182:399-411.
45. Jurynec MJ, Riley CP, Gupta DK, Nguyen TD, McKeon RJ, Buck CR: TIGR is upregulated in the chronic glial scar in response to central nervous system injury and inhibits neurite outgrowth. Mol Cell Neurosci 2003;23:69-80.